OncTalk 2018 - Newer Technologies in Radiation - Local Therapies for Metastatic Lung Cancer
OncTalk 2018 - Novel Indications for Local Therapy in Adv NSCLC - Local Therapies for Metastatic LC
OncTalk 2018 - Growing Potential Utility Surgery Advanced NSCLC - Local Therapies for Metastatic LC
OncTalk 2018 - Systemic Therapies for Advanced NSCLC - Local Therapies for Metastatic LC
OncTalk 2018 - Panel Discussion and Q&A - Local Therapies for Metastatic LC
OncTalk 2019 - Overview
Treatment Options for Newly Diagnosed AML: Venetoclax and Midostaurin - Blood Cancer OncTalk
Locally Advanced NSCLC: Treatment Goals and Challenges
Practice Changes for Use of Immunotherapy in NSCLC: Q&A
Immunotherapy Paradigm for Newly Diagnosed NSCLC
Locally Advanced NSCLC: Audience Q&A
Panel Discussion: Treatment and Follow-up of Low Risk Patients
Anthony Beukes - Creating an Event Management Service Using HL7 FHIR | DevDays 2018 Amsterdam
Sjöberg Laureate brings new hope to people with lung cancer
ASCO 2018 Keynote189 - Cisplatin or Carboplatin with Alimta & Keytruda - Practice Changing Approach?
Treating Uncommon EGFR NSCLC Mutations with Osimertinib
Increased progression free survival for patients with metastatic head and neck cancer using afatinib
Dr. Vallieres on Postoperative QoL in Patients With Lung Cancer
Dr. Choy Discusses Therapy for Oligometastatic Lung Cancer
Clinical Trial for Metastatic Lung Cancer